Search research articles
Contact Us
Filters
Showing results (321-330 of 342) with videos related to
Page
of 35
Sort By:
Current Biology : CB
|
February 8, 2005
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
E Elizabeth Patton, Hans R Widlund, Jeffery L Kutok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
Charles D Blanke, Cathryn Rankin, George D Demetri, et al.
The Journal of Pathology
|
June 2, 2006
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J S Reis-Filho, C Pinheiro, M B K Lambros, et al.
Histopathology
|
December 4, 2022
Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Judith V M G Bovée, Fleur Webster, Fernanda Amary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Histopathology
|
March 17, 2023
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms
Sanhong Yu, Lynette M Sholl, Stephanie Siegmund, et al.
The Journal of Pathology
|
November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
Subbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
Histopathology
|
October 13, 2022
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series
Katrina Collins, Lynette M Sholl, Stephanie Siegmund, et al.
Nature Genetics
|
May 6, 2014
Dystrophin is a tumor suppressor in human cancers with myogenic programs
Yuexiang Wang, Adrian Marino-Enriquez, Richard R Bennett, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 342) with videos related to
Sort By:
Page
of 35
Current Biology : CB
|
February 8, 2005
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
E Elizabeth Patton, Hans R Widlund, Jeffery L Kutok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
Charles D Blanke, Cathryn Rankin, George D Demetri, et al.
The Journal of Pathology
|
June 2, 2006
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J S Reis-Filho, C Pinheiro, M B K Lambros, et al.
Histopathology
|
December 4, 2022
Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Judith V M G Bovée, Fleur Webster, Fernanda Amary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Histopathology
|
March 17, 2023
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms
Sanhong Yu, Lynette M Sholl, Stephanie Siegmund, et al.
The Journal of Pathology
|
November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
Subbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
Histopathology
|
October 13, 2022
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series
Katrina Collins, Lynette M Sholl, Stephanie Siegmund, et al.
Nature Genetics
|
May 6, 2014
Dystrophin is a tumor suppressor in human cancers with myogenic programs
Yuexiang Wang, Adrian Marino-Enriquez, Richard R Bennett, et al.
Page
of 35